Recurrence in operated patients with laryngeal squamous cell carcinoma

Journal Title: Otolaryngologia Polska - Year 2009, Vol 63, Issue 5

Abstract

Purpose: The aim of the present study was to investigate the recurrence prevalence in patients with laryngeal squamous cell carcinoma (LSCC) underwent surgery as primary treatment. Material: The assessed group consisted of 148 patients with operable LSCC underwent surgery as primary treatment between 1999-2002. Surgery was performed in all cases. Total laryngectomy was performed in 107 (72.3%) patients and laser endoscopic tumor resection was performed in 41 (27.7%) patients. Results: Local recurrence occurred in 18 (12.2%) patients, nodal recurrence in 12 (8.1%) and both and/or remote metastases in 6 (4%) patients. Altogether, recurrence was present in 36 (24.3%) patients and 111 (75.7%) patients had no symptoms of recurrence. Recurrence prevalence in 3-year follow-up - prevalence of recurrence signifi cantly increased with tumor’s T feature (p=0.04), N feature (p=0.03), progression of clinical stage (p=0.008) and histological malignancy G stage (p=0.01). Recurrence prevalence in 5-year follow-up – prevalence of recurrence signifi cantly increased with tumor’s T feature (p=0.02), N feature (p=0.01), progression of clinical stage (p=0.003) and histological malignancy G stage (p=0.002). Tumors localized in glottic area had less recurrences than those localized in supraglottic area (p=0.05). There were no signifi cant dependence between recurrence type (local or nodal) and tumor’s clinicopathological features. Multiple factor analysis with logistic regression model did not revealed simultaneous infl uence of many variables on recurrence’s presence and type. Using multiple factor analysis with Cox’s regression model it was proved that recurrence presence (p< 0.00001) is a signifi cant independent prognostic factor in the analyzed group of patients with laryngeal carcinoma in 3-year follow-up. Conclusions: Recurrence prevalence depends on localization, systemic progression stage, clinical progression stage, cervical lymph nodes state and histological malignancy stage of tumor. Patients with local recurrence have statistically signifi cantly worse prognosis than patients with no recurrence. Recurrence presence is signifi cant independent prognostic factor in 3-year follow-up.

Authors and Affiliations

Kamal Morshed, Marcin Szymański, Marek Zadrożniak, Henryk Siwiec, Agnieszka Wawrzecka, Rashad Abushammalah, Agata Smoleń

Keywords

Related Articles

Our experience in the treatment advanced neoplasms of floor of the mouth

SUMMARY Aim: The aim of this study was to evaluate results of our surgical treatment of advanced neoplasms of the floor of the mouth, treated from 2005-2011 in Department of Otolaryngology and Department of Plastic Surge...

Diagnostyka preimplantacyjna w kierunku niedosłuchu wrodzonego z mutacją 35deIG w genie GJB2 — doniesienie wstępne

SUMMARY Introduction: 35deIG mutation in GJB2 gene is the most frequent mutation in genetic hearing loss. The carrier screening for 35deIG mutation to identify affected newborns is at the moment relatively inexpensive me...

Intranasal glucocorticosteroids – Not only in allergic rhinitis In the 40th anniversary of intranasal glucocorticosteroids' introduction

It has been 40 years since Niels Mygind's publication in British Medical Journal on intranasal application of beclomethasone dipropionate aerosol in allergic rhinitis (AR). Since then a new era in treatment of allergic a...

The case of malignant melanoma of the external ear with hidden location

Melanoma is one of the most malignant neoplasm. Mostly it is located in skin but also can appear in every place where melanocytes are present. Approximately 25% of all of these tumours is located in head and neck region...

Download PDF file
  • EP ID EP51805
  • DOI -
  • Views 138
  • Downloads 0

How To Cite

Kamal Morshed, Marcin Szymański, Marek Zadrożniak, Henryk Siwiec, Agnieszka Wawrzecka, Rashad Abushammalah, Agata Smoleń (2009). Recurrence in operated patients with laryngeal squamous cell carcinoma. Otolaryngologia Polska, 63(5), 419-428. https://www.europub.co.uk/articles/-A-51805